Delivery Order SPE2DB20D1109-SPE2DB25FN47P
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a Firm Fixed Price Delivery Order for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $3,534.72, is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of January 23, 2025. The contract is not designated as a set-aside, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,429.81 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a 60 ml medication. The contract has an ultimate completion date of November 1, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract is a firm fixed-price delivery order valued at $3,189.87, with an ultimate completion date of January 23, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.16 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,221.49, is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. This is a firm fixed-price delivery order contract with a period of performance through January 29, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml bottle. The $3,685.69 firm fixed-price delivery order has a completion date of June 8, 2023 and was awarded on June 7, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $1,862.14, is for the supply of Quillivant XR 25 mg/5 mL suspension. The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,190.51, is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml containers. The contract has a firm fixed price and will run through November 27, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The $1,672.68 firm-fixed-price delivery order has an ultimate completion date of October 23, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...